Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1973 4
1974 2
1975 2
1976 5
1977 2
1978 4
1979 3
1980 9
1981 11
1982 6
1983 17
1984 11
1985 16
1986 9
1987 8
1988 14
1989 20
1990 32
1991 33
1992 25
1993 19
1994 17
1995 23
1996 25
1997 42
1998 15
1999 8
2000 5
2001 1
2002 3
2003 1
2004 2
2005 2
2006 4
2007 2
2008 2
2009 1
2010 3
2011 3
2012 2
2013 1
2014 1
2017 1
2018 2
2020 1
2021 2
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

422 results

Results by year

Filters applied: . Clear all
Page 1
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M, Peter N, Bokemeyer C, Eimermacher H, Ho A, Hoffmann M, Mertelsmann R, Trümper L, Balleisen L, Liersch R, Metzner B, Hartmann F, Glass B, Poeschel V, Schmitz N, Ruebe C, Feller AC, Loeffler M; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Pfreundschuh M, et al. Among authors: mertelsmann r. Lancet Oncol. 2008 Feb;9(2):105-16. doi: 10.1016/S1470-2045(08)70002-0. Epub 2008 Jan 15. Lancet Oncol. 2008. PMID: 18226581 Clinical Trial.
Lymphokine activated killer cells.
Lindemann A, Herrmann F, Oster W, Mertelsmann R. Lindemann A, et al. Among authors: mertelsmann r. Blut. 1989 Oct;59(4):375-84. doi: 10.1007/BF00321208. Blut. 1989. PMID: 2676022 Review.
[Tumor necrosis factor].
Herrmann F, Mertelsmann R. Herrmann F, et al. Among authors: mertelsmann r. Dtsch Med Wochenschr. 1989 Feb 24;114(8):312-6. doi: 10.1055/s-0029-1235647. Dtsch Med Wochenschr. 1989. PMID: 2646094 Review. German. No abstract available.
Interleukin-3 and its receptor.
Lindemann A, Mertelsmann R. Lindemann A, et al. Among authors: mertelsmann r. Cancer Treat Res. 1995;80:107-42. doi: 10.1007/978-1-4613-1241-3_5. Cancer Treat Res. 1995. PMID: 8821576 Review. No abstract available.
Clinical effects of recombinant human interleukin-3.
Ganser A, Lindemann A, Seipelt G, Ottmann OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: mertelsmann r. Am J Clin Oncol. 1991;14 Suppl 1:S51-63. doi: 10.1097/00000421-199112001-00010. Am J Clin Oncol. 1991. PMID: 2048566 Review.
Interleukin-3: structure and function.
Lindemann A, Mertelsmann R. Lindemann A, et al. Among authors: mertelsmann r. Cancer Invest. 1993;11(5):609-23. doi: 10.3109/07357909309011680. Cancer Invest. 1993. PMID: 8402229 Review. No abstract available.
[Current treatment concepts of lung cancer].
Kaiser F, Engelhardt M, Rawluk J, Mertelsmann R, Passlick B, Wäsch R. Kaiser F, et al. Among authors: mertelsmann r. Dtsch Med Wochenschr. 2011 Sep;136(38):1901-6. doi: 10.1055/s-0031-1286361. Epub 2011 Sep 13. Dtsch Med Wochenschr. 2011. PMID: 21915805 Review. German.
A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.
Croockewit AJ, Bronchud MH, Aapro MS, Bargetzi MJ, Crown J, Gratwohl A, Lange W, Ludwig H, Martinelli G, Mertelsmann R, Nuessler V, Willemze R, De Witte TJ, Zittoun R, Zwierzina H. Croockewit AJ, et al. Among authors: mertelsmann r. Eur J Cancer. 1997 Oct;33(11):1732-46. doi: 10.1016/s0959-8049(97)00222-0. Eur J Cancer. 1997. PMID: 9470826 Review. No abstract available.
422 results